← Browse by Condition
Medical Condition

relapsed refractory acute lymphoblastic leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT07361029 Phase 1
Recruiting

CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

Enrollment
24 pts
Location
Saudi Arabia
Sponsor
King Faisal Specialist Hospita...
View Trial →